Syngenta obtains license from Broad Institute for CRISPR technologyFeedstuffs“Gaining access to CRISPR-Cas9 technology will allow us to accelerate the rate of innovation in the development of new plant varieties, and bring novel traits into the hands o… Continue reading
Sarepta on go with early-stage study of gene therapy GALGT2 for DMD; shares up 1% premarketSeeking AlphaSarepta Therapeutics (NASDAQ:SRPT) is up 1% premarket on light volume on the heels of its announcement that the FDA has signed off on its IND for ge… Continue reading
Nature.comGut microbes can shape responses to cancer immunotherapyNature.comThey also highlight the impact of antibiotics on cancer immunotherapies, particularly drugs that block either of two related proteins called PD-1 and PD-L1. One of the studies … Continue reading
Futurity: Research News |
Gel grows more stem cells with 100x less space
Futurity: Research News Researchers have created a kind of gel that allows them to grow huge numbers of stem cells with much less space, solving some of the biggest problems with producing new stem cells. “We just don’t know how to efficiently and effectively grow massive … |
BioPharma-Reporter.com |
Juno: Centralised approach key to manufacturing CAR T therapies
BioPharma-Reporter.com Chimeric antigen receptor (CAR) T-cell therapies involve harvesting a patient’s own T-cells, genetically modifying and multiplying them ex vivo, then infusing them back into the patient. The harvest and infusion takes place at a hospital or a clinic … |
Medical Xpress |
‘Super T cells’ engineered for optimal performance drive new gene–therapy approach
Medical Xpress But efforts to develop adoptive T cell therapies for solid tumors have hit upon a number of challenges; the only gene therapies to show significant benefit for patients have been in liquid tumors—forms of leukemia and lymphoma. “What we see over and … |